Chemoinformaics analysis of 2-Butyne-1,4-diol
Molecular Weight | 86.09 | nRot | 0 |
Heavy Atom Molecular Weight | 80.042 | nRig | 1 |
Exact Molecular Weight | 86.0368 | nRing | 0 |
Solubility: LogS | 0.867 | nHRing | 0 |
Solubility: LogP | -1.088 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 12 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 12.2848 |
nHD | 2 | BPOL | 6.01924 |
QED | 0.37 |
Synth | 3.053 |
Natural Product Likeliness | 0.776 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.017 |
Pgp-sub | 0.001 |
HIA | 0.032 |
CACO-2 | -4.335 |
MDCK | 0.000404569 |
BBB | 0.993 |
PPB | 0.362636 |
VDSS | 0.586 |
FU | 0.623584 |
CYP1A2-inh | 0.041 |
CYP1A2-sub | 0.098 |
CYP2c19-inh | 0.025 |
CYP2c19-sub | 0.401 |
CYP2c9-inh | 0.005 |
CYP2c9-sub | 0.196 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.157 |
CYP3a4-inh | 0.004 |
CYP3a4-sub | 0.103 |
CL | 5.085 |
T12 | 0.907 |
hERG | 0.002 |
Ames | 0.243 |
ROA | 0.965 |
SkinSen | 0.872 |
Carcinogencity | 0.228 |
EI | 0.996 |
Respiratory | 0.82 |
NR-Aromatase | 0.013 |
Antiviral | No |
Prediction | 0.984427 |